First Quadrant’s ChemoCentryx, Inc. CCXI Stock Holding History

First Quadrant’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-23,349	Closed	-$173K	–	990
2017 Q3	$173K	Hold	23,349	–	–	﹤0.01%	735
2017 Q2	$219K	Buy	+23,349	New	+$171K	﹤0.01%	669

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

First Quadrant's CCXI Position: Q4 2017 in Review

First Quadrant sold out of ChemoCentryx, Inc. (CCXI) in Q4 2017, closing a stake of 23,349 shares — an estimated $173K sold.

First Quadrant first reported a position in CCXI in Q2 2017 and held it in 2 quarters. The position peaked at $219K in Q2 2017. 87 funds tracked by Wall St. Rank hold CCXI as of Q4 2017.

First Quadrant reported no remaining ChemoCentryx, Inc. position as of Q4 2017 after selling out during the quarter.
First Quadrant sold 23,349 ChemoCentryx, Inc. shares in Q4 2017, an estimated $173K.
First Quadrant first reported a position in ChemoCentryx, Inc. in Q2 2017 and held it in 2 quarters.
First Quadrant's ChemoCentryx, Inc. position peaked at $219K in Q2 2017.
87 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2017.

Based on First Quadrant's 13F filing for Q4 2017, filed 23 Jan 2018.